Latest AI and machine learning research in allergy for healthcare professionals.
Despite biomarker-guided treatment strategies, clinical outcomes among patients with type 2 (T2)-high asthma remain heterogeneous, with some patients responding poorly to T2-targeted biologic therapies. We developed a contrastive machine learning method for patient stratification based on whole-blood DNA methylation (DNAm), applying it to pediatric asthma cohorts of Latino (discovery; n=1,016) and...
Microsatellite instability (MSI) is a key biomarker for immunotherapy response and prognosis across multiple cancers, yet its identification from routine Hematoxylin and Eosin (H&E) slides remains challenging. Current deep learning predictors often operate as black-box, weakly supervised models trained on individual slides, limiting interpretability, biological insight, and generalization; particu...
Immunotherapy has improved outcomes for advanced-stage melanoma, however, predictive biomarkers remain limited. We evaluated whether computed tomograp...
Cancer therapeutic response patterns may be fundamentally influenced by embryonic germ layer origin. Emerging evidence suggests mesoderm-derived malig...
Immune checkpoint inhibitors have become standard care across many cancers, but most patients do not respond. Predicting response remains challenging ...
The rapid integration of Large Language Models (LLMs) into healthcare raises critical questions regarding their safety and reliability. While models o...
Neoadjuvant chemotherapy (NAC) is the standard of care for locally advanced breast cancer. However, the disconnect between efficacy in randomized tria...
Severe cutaneous adverse reactions (SCARs), including Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS-TEN), drug reaction with eosinophilia a...
Large language models (LLMs) have shown incredible promise in medicine. While LLMs may be particularly useful in areas requiring extensive review of c...
Immunotherapy has improved outcomes in non-small cell lung cancer (NSCLC), but only a subset of patients achieves durable survival benefit. Convention...
Keratoconus (KC) is a prevalent ectatic corneal disease and the leading cause of corneal transplantation globally. Despite evidence of mitochondrial a...
BACKGROUND: Lung adenocarcinoma (LUAD) is a major cause of cancer mortality. Considering the critical role of tumor infiltrating lymphocytes in effect...
BACKGROUND: Although immune checkpoint inhibitors (ICIs) represent a substantial breakthrough in cancer treatment, it is crucial to acknowledge that t...
Survival is the gold standard in oncology when determining the real impact of therapies in patients outcome. Thus, identifying molecular predictors of...
BACKGROUND: Triple-negative breast cancer (TNBC) is a highly aggressive subtype with limited therapeutic targets and poor immunotherapy outcomes. The ...
BACKGROUND: Ensuring antibiotics are prescribed only when necessary is crucial for maintaining their effectiveness and is a key focus of public health...
Genetic perturbation of T cell receptor (TCR) T cells is a promising method to unlock better TCR T cell performance to create more powerful cancer imm...
Due to considerable tumour heterogeneity, stomach adenocarcinoma (STAD) has a poor prognosis and varies in response to treatment, making it one of the...
It is critical to appreciate the role of the tumour-associated microenvironment (TME) in developing strategies for the effective therapy of cancer, as...
MOTIVATION: T-cell receptors (TCRs) elicit and mediate the adaptive immune response by recognizing antigenic peptides, a process pivotal for cancer im...